Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
|
In vitro display technology is a cutting-edge cell-free genotype-phenotype coupling screening technology. It fundamentally breaks the inherent limitations of traditional in vivo cell display systems based on bacteria and yeast. All protein and polypeptide expression, display, panning and enrichment procedures are performed in a controlled ex vivo system. |
The core principle is precise coupling of molecular functional phenotypes with nucleic acid genotypes. Through multiple rounds of gradient pressure screening, high-specificity, high-affinity and high-stability target molecules are rapidly enriched from ultra-large mutation libraries. It constitutes the fundamental upstream core technology supporting the research and development of antibody therapeutics, peptide pharmaceuticals and raw materials for in vitro diagnostics.
Creative Biolabs boast years of experience in in vitro display technologies with a mature one-stop screening R&D platform.
Mature technology with high-cost performance. Suitable for conventional antibody and polypeptide screening, serving as the preferred general solution for innovative drug and diagnostic raw material development.
Eukaryotic expression system with quantitative sorting. Featuring post-translational modifications and correct protein folding, it is the premier choice for multi-parameter FACS-based screening, specific epitope targeting, and precise affinity maturation of human antibodies.
Host-free restriction and ultra-large library capacity. Ideal for high-complexity mutation library screening and in-depth affinity maturation of target molecules.
Ultra-high screening precision with low background noise. Optimized for high-specificity, low off-target screening and fine-grained draggability optimization.
for full process and solution details.
Breaking the five major industry bottlenecks: limited library capacity, prolonged cycles, unsolvable difficult targets, insufficient precision, and high trial-and-error costs.
Full services from library construction, screening to functional validation cut your R&D timeline and experimental costs.
Fully covering the whole industrial chain of biomedicine, in vitro diagnosis and basic scientific research.
Full coverage of screening, sequence optimization and affinity maturation for monoclonal antibodies, antibody fragments (scFv, Fab, etc.). Adaptable to oncology, autoimmune diseases, anti-infection and more.
Screening high-affinity, high-stability and low-immunogenicity targeted peptides, applicable to peptide innovative drugs, cell targeting probes and drug delivery carriers.
High-throughput screening of high-specificity, low cross-reactivity diagnostic antigens and antibodies. Compatible with chemiluminescence, colloidal gold, fluorescence detection and more.
Precise screening of viral neutralizing antibodies and protective antigen epitopes to promote the iteration of preventive and therapeutic vaccines, solving ambiguous target screening and weak protective efficacy.
Creative Biolabs provide standardized, modular and directly purchasable full-process outsourcing services for in vitro display technology.
Skip in-house lab construction and on your projects.
A wealth of novel pharmaceutical and IVD reagent programs, plus academic research projects, have been completed with success rates far surpassing industry standards.
Core team consists of biomedical PhDs and senior engineers with over ten years of experience in upstream drug screening, molecular modification and diagnostic raw material development.
Standardized full-cycle QC runs through library generation, screening and data verification, fully meeting all compliance standards for biomedical research.
for 1V1 expert docking, free solution matching and project feasibility evaluation.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
